arthritis {CopulaREMADA} | R Documentation |
The rheumatoid arthritis data
Description
Data obtained from a meta-analysis that aimed to determine whether anti-cyclic citrullinated peptide (anti-CCP) antibody identifies more accurately patients with rheumatoid arthritis than rheumatoid factor (RF) does. We include N=22
studies that assessed both RF and anti-CCP2 antibody for diagnosing rheumatoid arthritis.
Format
A data frame with 22 observations on the following 8 variables.
- TP1
the number of true positives for RF
- FN1
the number of false negatives for RF
- FP1
the number of false positives for RF
- TN1
the number of true negatives for RF
- TP2
the number of true positives for anti-CCP2
- FN2
the number of false negatives for anti-CCP2
- FP2
the number of false positives for anti-CCP2
- TN2
the number of true negatives for anti-CCP2
References
Nishimura, K., Sugiyama, D., Kogata, Y., et al. (2007) Meta-analysis: Diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Annals of Internal Medicine, 146(11), 797–808.
Dimou, N.L., Adam, M. and Bagos, P.G. (2016) A multivariate method for meta-analysis and comparison of diagnostic tests. Statistics in Medicine, 35(20), 3509–3523.